Drug Trial Radar · NCT03516305
Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers
Last checked: Nov 20, 2026Latest source record: Apr 7, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Apr 6, 2018
Primary completion
Aug 1, 2018
Study completion Aug 1, 2018
Sponsor
- Lead sponsor
- Engage Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Clinilabs, Inc.
- First posted
- May 4, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is an open-label, non-randomized, single dose, pharmacokinetic study in 36 healthy adult male and female volunteers, including 18 smokers and 18 non-smokers. All subjects will be administered a single inhaled dose of Staccato alprazolam 1 mg via hand-held inhaler. Blood samples will be drawn for pharmacokinetic analysis. Eligible subjects are admitted to Phase 1 unit for up to 48 hours. Subjects will receive a post-study safety phone call 14 days(± 2 days) after dosing.
Conditions
- Healthy
Interventions
Staccato Alprazolam 1 mgDrug
alprazolam I mg administered via the Staccato hand-held inhaler device system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK) : Maximum observer drug concentration (Cmax)Time frame: Sequential time points : pre-dose, and at 2, 5, 10 and 30 minutes, and at 1, 2, 4, 6, 12, 24 and 36 hours post-dose.
- PK: Area under the concentration versus time curve (AUC)from Zero to Infinity (AUC[0-∞]Time frame: Sequential time points : pre-dose, and at 2, 5, 10 and 30 minutes, and at 1, 2, 4, 6, 12, 24 and 36 hours post-dose.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinilabs Research Unit
Eatontown, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.